Improving epilepsy treatment in Africa
The NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded £4.9 million to help fund a project investigating epilepsy in sub-Saharan Africa.
Read moreSHElock Holmes - inspiring girls with science
On 27 July, 16 girls aged between 11-14 joined the SHElock team from our Wellcome Centre for Integrative Neuroimaging.
Read moreNDCN staff win teaching awards
The 2019 MSD Teaching Excellence Awards were celebrated in a ceremony at Merton College on Wednesday 23 October.
Read moreTimothy Behrens recognised in prestigious Blavatnik Awards for Young Scientists
Professor Timothy Behrens has been recognised for ground-breaking contributions to translational research.
Read moreGene therapy shows promise in tackling common cause of childhood blindness
The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.
Read moreGift boosts research into UK’s biggest cause of sight loss
£277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.
Read moreFrom our Head of Department
Welcome to the Nuffield Department of Clinical Neurosciences (NDCN), one of the World's leading centres for research and treatment in disorders of the nervous system.
Working with us
We are committed to helping all staff and students reach their potential and achieve a good work-life balance.
Take part in our research
What's new
Gene therapy shows promise in tackling common cause of childhood blindness
27 February 2020
The results of a first-in-human clinical trial of gene therapy to treat a common cause of genetic blindness have shown partial reversal of sight loss in some patients.
Gift boosts research into UK’s biggest cause of sight loss
18 February 2020
£277,000 from the estate of Jean Williams will support cutting-edge studies into macular disease, which affects nearly 1.5 million people.
Improving epilepsy treatment in Africa
11 February 2020
The NIHR Research and Innovation for Global Health Transformation (RIGHT) programme has awarded £4.9 million to help fund a project investigating epilepsy in sub-Saharan Africa.
Our researchers test ‘Viagra’ drug to prevent recurrent strokes
17 January 2020
Researchers in our Centre for the Prevention of Stroke and Dementia have begun a clinical trial to assess whether the drug sildenafil could improve blood flow to the brain.
AT A GLANCE
Events
